ILMN vs PEN · rev $2.25B vs P/E 237, rev $764.8M
Illumina Inc (ILMN) versus Penumbra Inc (PEN) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Penumbra Inc (PEN) is a medical devices company listed on US.
Latest reported ILMN revenue for 2026-06-28 was $2.25B. Net income was $340.0M. ILMN currently screens at market cap $15.84B.
Latest reported PEN revenue for 2026-06-30 was $764.8M. Net income was $67.4M. PEN currently screens at market cap $9.93B and trailing P/E 237.4.
ILMN currently screens at market cap $15.84B. PEN currently screens at market cap $9.93B and trailing P/E 237.4.
Not investment advice. Open the ILMN and PEN stock pages for the full models.
Not investment advice.